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Summary. Erythrocyte membranes from an anaemic patient 
receiving gold therapy for rheumatoid arthritis had reduced 
P-sialoglycoprotein (j-SGP) content but normal expression of 
sialoglycoproteins a. 6 and y. Elliptocytes were present in the 
peripheral blood. The serum of the patient contained anti$- 
SGP which did not appear to bind to her own cells. It reacted 
with all erythrocytes apart from P-SGP deficient Leach 
phenotype cells. The antibody was inhibited by purified /3- 
SGP from normal red cells, bound to p-SGP on immunoblots 
and also reacted with the abnormal p-related-SGP in erythro- 
cyte membranes of both the Gerbich type and Yus type of 
Gerbich negative. Two years later the patient was no longer 
anaemic, no elliptocytes were seen in her peripheral blood 
film and her erythrocyte membranes had normal P-SGP 
content. Antibody was no longer present in her serum and 
antibody from the earlier sample now reacted with the 
patient's erythrocytes. 
Erythrocyte membrane p-SGP is known to be important in 
the maintenance of normal cell shape. It is likely that the 
transient occurrence of elliptocytes in the patient resulted 
from the concurrent temporary reduction in /3-SGP content of 
her erythrocyte membranes. 
The human erythrocyte membrane contains at least four 
different sialoglycoproteins (SGPs). a, p, y and 6 (for review 
see Anstee & Tanner, 1986). There is now substantial 
evidence that two of these SGPs. P (syn: glycoconnectin, 
glycophorin C) and y, are directly involved in the main- 
tenance of erythrocyte shape (Mueller & Morrison, 1981). 
Gerbich (Ge) is a blood group comprising at least two 
erythrocyte antigens of very high frequency in most popula- 
tions (for review see Race &Sanger, 1975: Reid, 1986). There 
are at least three Ge-negative phenotypes, the original 
Gerbich type (Ge:-2,-3), the Yus type (Ge:-2,3) and the Leach 
phenotype (also Ge:-2,-3). Unlike the other two Ge-negative 
types, the Leach phenotype is characterized by elliptocytosis. 
Leach phenotype erythrocytes lack SGPs /3 and y in the cell 
membrane, fail to react with murine monoclonal antibodies 
directed at a portion of P-SGP (Anstee et al, 1984a; Daniels et 
al. 1986: Reid et nl. 1 9 8 7 ~ ) .  and have marked reduction in 
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both membrane mechanical stability and membrane deform- 
ability, providing clear evidence of an important functional 
role for P and y SGPs in normal erythrocytes (Reid et al, 
198 7b). 
Recently, Beattie & Sigmund (1 9 8 7) described a severely 
anaemic patient with elliptocytosis who had received gold 
therapy for rheumatoid arthritis and who had produced a Ge- 
like antibody. In this paper we report a detailed study of the 
erythrocyte membranes of this patient and of the immuno- 
chemical specificity of her antibody. The results show that the 
antibody may have been anti-P-SGP and that elliptocytosis. 
which was transient, was associated with a transient reduc- 
tion in the membrane content of P-SGP. We believe this to be 
the first report of an acquired P-SGP deficiency. 
MATERIALS AND METHODS 
Materials. Blood samples from the patient were collected 
during her aplastic crisis (October 1982 and November 
1982) and during remission (October 1984). For long-term 
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storage, the red cells were stored in liquid nitrogen and the 
plasma samples stored at - 20°C. 
Human alloantibodies were gifts from a variety of sources, 
as were erythrocytes from Ge-negative donors. For immuno- 
blotting and haemagglutination tests against sialidase- 
treated erythrocytes, and against Tn and Cad erythrocytes, 
the human antibodies were purified as described by Tanner et 
a1 (1988). A rabbit antiserum, reactive with the cytoplasmic 
portions of SGPs P and y ,  was prepared as described (Reid et al, 
1987a). Purified /I-SGP was prepared as described by Reid et 
al ( 198 7 4 .  Endoglycosidase F/peptidyl-N-glycosidase F 
(Endo F) preparations were prepared and used as described in 
Tanner et al(1988). 
Serological methods. Standard serological methods were 
used. For antiglobulin tests polyspecific anti-human globulin 
was used for human antibodies, and anti-mouse IgG (pro- 
vided by Dr R. W. Knowles) for murine monoclonal anti- 
bodies. Red cells were treated with proteases and sialidase as 
described previously (Anstee et al, 1984b). For haemaggluti- 
nation inhibition tests a volume of serum was incubated with 
an equal volume of inhibitor for 20 min at room temperature 
before adding a volume of the appropriate erythrocyte 
suspension followed by an indirect antiglobulin test. 
Biochemical methods. Sodium dodecyl sulphate (SDS)- 
polyacrylamide gel electrophoresis of erythrocyte mem- 
branes was carried out on gels containing 10% acrylamide 
with a 3% overlay using the method of Laemmli (1  970). The 
protein concentration of erythrocyte membranes was deter- 
mined by the method of Lowry et a1 (1 9 5 1) in the presence of 
0.1% SDS. Periodic acid Schiff s base (PAS) stained gels were 
scanned at 5 5 0  nm on a Beckman scanning spectrophoto- 
meter and the areas calculated using a lowest valley 
integration method. The relative concentration of spectrin, 
protein 4.1 and band 3 was determined by pyridine elution 
(Agre et al. 1985). Immunoblotting was as described by 
Mallinson et a1 (1986), except that 5% (w/v) bovine milk 
powder in phosphate-buffered saline (PBS) at pH 7.4 was 
used as the blocking agent. Binding of antibodies was 
detected using peroxidase-conjugated goat anti-mouse IgG, 
anti-human IgG or anti-rabbit IgG (BioRad. Richmond, 
Calif.). 
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RESULTS 
Serological results on the erythrocytes of the patient 
The following findings were obtained on the patient’s 
erythrocytes during the time antibody was present in her 
serum (1982 sample). They reacted with six examples of 
alloanti-Ge3 (sera of Gerbich or Leach type individuals) and 
29 examples of alloanti-Ge2 (sera of Yus type and some 
Gerbich or Leach type individuals). Titration of Ge antisera 
with the patient’s cells, and tests both before and after 
treatment of the cells with proteases. showed that the 
patient’s cells expressed normal amounts of Ge antigens as 
determined by human alloantibodies and that their Ge 
antigens, like those of normal erythrocytes, were sensitive to 
treatment with papain or trypsin. 
When the anti-B-SGP monoclonal antibodies GERO 
(Daniels et al, 1983) and BRIC 10 (Anstee et al, 1984a. b) 
were used the patient’s cells behaved like most Ge-negative 
cells: they were not agglutinated by the antibodies directly 
but reacted strongly by the antiglobulin test. After trypsin 
treatment the patient’s cells did not react with the monoclon- 
al antibodies by either method. In titrations with the 
monoclonal antibodies by the antiglobulin method, the 
patient’s cells gave similar or only slightly lower scores than 
did Ge-positive control cells. 
Ge-negative erythrocytes of both Gerbich and Leach types, 
but not of the Yus type, usually show reduced strength of 
expression of Kell and para-Kell blood group antigens 
(Daniels, 1982: Anstee et al, 1984a, b: Daniels et al, 1986; 
Reid et al, 1987~) .  The patient’s erythrocytes were K - k +  
Kp(a-b+c-) Js (a -b+)  K: 11,-17 Ul(a-) Ku+ K: 12, 
13, 18, 22. No weakness was apparent in the expression of 
any of the high frequency Kell or para-Kell antigens. The 
patient’s cells were not T active as determined by testing with 
Arachis hypogaea lectin. 
In 1984, when antibody could no longer be detected in the 
patient’s serum, her erythrocytes were Ge-positive as before 
but now resembled other Ge-positive erythrocytes by being 
agglutinated directly and indirectly by monoclonal anti-8- 
SGP. 
The erythrocyte membranes 
Erythrocyte membranes prepared from patient samples 
collected in 1982 and 1984, and adjusted to the same protein 
concentration, were analysed by SDS-PAGE with subsequent 
PAS staining. The results demonstrated normal staining of 
bands containing SGPs a, S and y in both samples. However, 
whilst normal staining of P-SGP was apparent in the 1984 
sample, markedly reduced staining of P-SGP was evident in 
the 1982 sample (Fig la). Quantitation of the staining 
intensity of the /3-SGP band in the 1982 sample by densito- 
metry indicated that p was about 35% of normal levels. 
When the gels were stained for protein with Coomassie blue, 
no differences from normal were observed with membranes 
from either 1982 or 1984 samples (data not shown). The 
ratios of spectrin :band 4.1 :band 3 were within normal limits 
in these samples. 
The marked reduction in 8-SGP was again apparent by 
immunoblotting with monoclonal anti-B-SGP (BRIC 10) 
(Fig le). When immunoblotting was carried out using a 
human alloanti-Ge3, which recognizes an extracellular 
antigenic determinant common to both B and y SGPs (Reid et 
al, 1987a). reduced staining of /I-SGP was again apparent in 
the 1982 sample, while staining of y-SGP was comparable to 
normal control samples (Fig l j ) .  Normal y-SGP levels were 
also noted using human alloanti-Ge2 (Fig lh) .  
Since both the PAS stain and the anti-B-SGP and anti- 
B + y - SGP reagents are dependent on the presence of sialic 
acid on B-SGP for reactivity (Anstee et al, 1984b: Reid et al, 
1987a). the possibility existed that the apparent reduction of 
B-SGP in the 1982 sample was the result of a glycosylation 
abnormality, rather than a total reduction in P-SGP content. 
Immunoblots were therefore carried out using a rabbit 
antiserum rendered specific for the cytoplasmic portions of 
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Fig 1. SDS-polyacrylamide gel electrophoresis of erythrocyte membranes of the patient and determination of the specificity of the patient’s serum 
antibody. Tracks a and b: SDS-polyacrylamide gel electrophoresis of erythrocyte membranes from the patient (a, 1982 sample) and normal 
erythrocyte membranes (b) with subsequent PAS staining. Tracks c-e: Immunoblotting with murine monoclonal antibody BRIC 10. 
(c) membranes of Leach phenotype, (d) normal membranes, (e) membranes of patient (1982 sample). Tracks f-h: Immunoblotting with human 
alloanti-Ge2 (WHA), ( f )  Leach phenotype membranes, (g) normal membranes, (h) membranes of patient (1982 sample). Tracks i-k: 
Immunoblotting with human alloanti-Ge3 (4401 7 ) .  (i) normal membranes, (j)  membranes of patient (1982 sample), (k) membranes of Leach 
phenotype. Tracks I-n: Immunoblotting with rabbit antibody to the cytoplasmic portions of SGPs and 7, (I) normal membranes, (m) membranes 
of patient (1982 sample), (n) membranes of Leach phenotype. Tracks 0-r: Immunoblotting with antibody from the serum of the patient, (o),  
(r) normal membranes, (p) membranes of Leach phenotype, (9) membranes of patient (1982 sample). 
Fig 2. Morphology of erythrocytes from the patient. Photomicrograph of a smear of blood from the patient taken into EDTA. The sample is 
representative of the blood morphology of the patient between June 1982 and December 1983. 
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SGPs P and y. The results again showed reduced staining of 
P-SGP in the 1982 sample, although the reduction was not so 
marked as that seen with the sialic acid dependent antibodies 
(Fig lm). 
The specificity of the antibody in the serum of the patient 
The antibody in the serum of the 1982 sample behaved as an 
alloantibody: it could not be absorbed with the patient’s own 
cells that had also been collected in 1982. However, the 
antibody was not present in serum collected in 1984, and the 
original antibody reacted with the patient’s erythrocytes 
from the 1984 sample both by the antiglobulin test and 
weakly by direct agglutination. 
The antibody agglutinated Ge-positive cells and reacted by 
the antiglobulin test. It behaved like the monoclonal anti- 
bodies GERO and BRIC 10 in failing to agglutinate Ge 
negative erythrocytes of both Gerbich (six examples) and Yus 
(four examples) types in direct agglutination tests whilst still 
reacting with cells of either phenotype in antiglobulin tests: 
like the two monoclonals, the patient’s antibody failed to 
react with Leach phenotype cells (three examples) in either 
direct or indirect agglutination tests. The antibody could not 
be absorbed by Leach phenotype cells. 
The patient’s serum failed to react with Ge-positive 
erythrocytes treated with papain, ficin, trypsin or pronase but 
did react with a-chromotrypsin-treated erythrocytes. Like 
monoclonal anti-8-SGP, the patient’s antibody did not react 
with trypsin-treated Yus type cells but did react, both by 
direct and indirect agglutination, with trypsin-treated Ger- 
bich type cells. 
Purified antibody from the patient did not agglutinate 
sialidase-treated erythrocytes either directly or indirectly but 
did react with Cad 1 and Tn erythrocytes in indirect 
agglutination tests, although the reactions were weaker than 
with normal erythrocytes. In haemagglutination inhibition 
tests, purified P-SGP from normal erythrocytes completely 
inhibited the patient’s antibody. 
By immunoblotting. the patient’s purified antibody was 
clearly specific for P-SGP and did not react with y-SGP 
(Fig 10, r). The antibody also bound to the abnormal P-SGP- 
related sialoglycoproteins found in membranes from Gerbich 
type and from Yus type erythrocytes (data not shown). No 
reactivity was observed with Leach phenotype membranes 
which lack both P-SGP and y-SGP and do not contain the 
abnormal P-SGP-related components of Ge or Yus-type 
Gerbich-negative cells (Fig lp), or with membranes of 
autologous red cells collected in 1982 (Fig lq). With 
membranes derived from Endo F-treated normal erythro- 
cytes, the patient’s antibody reacted with the band corres- 
ponding to P-SGP after removal of the N-glycosidically-linked 
oligosaccharide (data not shown). The antibody also reacted 
by immunoblotting with the abnormal Pwb SGP of Wb- 
positive erythrocytes (data not shown) which are believed to 
have abnormal glycosylation (Reid et al, 1985). Collectively, 
these results imply that the reactivity of the patient’s 
antibody did not depend on the presence of the N-glycosidi- 
cally linked oligosaccharide normally found on P-SGP. 
Erythrocyte morphology 
Elliptocytes were present in peripheral blood films from the 
patient between June 1982 and December 1983 (Fig 2). No 
elliptocytes have been observed in subsequent blood films. 
DISCUSSION 
The patient reported here produced a Ge-like blood group 
antibody which behaved as an alloantibody. Two years later, 
the antibody was no longer detectable in the patient’s serum 
and her erythrocytes reacted with the antibody in her 
previous serum sample. 
We have shown that the patient’s antibody is specific for 
P-SGP. a molecule which has been well characterized (Dahr et 
al, 1982: Colin et al, 1986). The availability of antibodies to 
different antigenic determinants on both the extracellular 
and intracellular portions of P-SGP allowed us to obtain 
evidence that, at the time when the anti-8-SGP was detected, 
the content of P-SGP in the patient’s erythrocyte membranes 
was markedly reduced. That is, there was a reduction in the 
amount of the whole molecule in the membrane, and not 
simply a change which affected an extracellular region of the 
molecule involving a particular epitope, or group of epitopes. 
However, the patient’s red cells failed to adsorb her P-SGP- 
specific antibody, suggesting that this antibody was demon- 
strating some subtle qualitative difference between the 
residual P-SGP and normal P-SGP, not recognized by the 
murine monoclonal or rabbit antibodies. The y-SGP content 
of the patient’s erythrocyte membranes appeared normal. 
This apparently selective effect on 8-SGP. but not the 
structurally related y-SGP (Reid et al. 198 7a). is difficult to 
interpret. 
SGPs and y have a well-defined function, viz main- 
tenance of normal erythrocyte shape, deformability and 
membrane mechanical stability through interaction of the 
cytoplasmic portion of the molecule with the membrane 
skeleton (Mueller & Morrison, 1981: Anstee et al, 1984a, b: 
Reid et al. 1987b). Total absence of SGPs P and y, as occurs in 
erythrocytes of the Leach phenotype, is associated with 
elliptocytosis (Anstee et al. 1984a: Daniels et al, 1986: Reid et 
al, 1 9 8 7 ~ ) .  We suggest, but cannot prove, that the transient 
occurrence of elliptocytes in the peripheral blood of the 
patient described here. which occurred during the period 
when the P-SGP content of her erythrocyte membranes was 
reduced and disappeared when the P-SGP content returned to 
normal, resulted from the reduced /3-SGP content of her 
erythrocyte membranes. The anaemia, however, did not 
correlate with the abnormal serological and biochemical 
findings and probably resulted from the gold therapy. It is 
hoped that this report may lead to further examples of this 
phenomenon being recognized. 
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